STARTUP LEGAL15 Sept 2026
Delhi HC orders tax dept to refund ₹783 cr to Teva Israel over Ranbaxy payment | Company Business News
The Delhi High Court quashed tax proceedings against Teva, an Israeli drugmaker, over payments linked to Ranbaxy. It told the income tax department to refund about ₹783 crore, plus interest, within two months. That refund depends on Teva meeting court-set conditions. This matters for firms shifting payment rights between group companies abroad. Review your contracts' tax deduction clauses.
Key Statutory Highlights
- The Delhi High Court found the tax proceedings against Teva USA were time-barred and without jurisdiction, and quashed the notices and proceedings arising from them.
- The court directed the income tax department to refund about ₹783 crore, along with applicable interest, to Teva Israel within two months.
- The refund is subject to Teva complying with conditions the court imposed, including providing the required corporate guarantee or solvent surety.
Actionable Advice for Taxpayers / Founders:If your group moves payment rights or contracts between companies in different countries, review how tax is deducted and paid on those payments and keep your agreements and records ready. Speak to your CA before assuming a similar refund applies to your case.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: